Leukopenia News and Research

RSS
Leukopenia is a decrease in the number of white blood cells (leukocytes) found in the blood, which places individuals at increased risk of infection.
Olaparib effective against BRCA2-mutated prostate cancer

Olaparib effective against BRCA2-mutated prostate cancer

Letermovir: A promising breakthrough in CMV prevention for kidney transplant recipients

Letermovir: A promising breakthrough in CMV prevention for kidney transplant recipients

The safety and tolerability of Remdesivir in children affected by COVID-19

The safety and tolerability of Remdesivir in children affected by COVID-19

Novel T cell receptor therapy shows early promise for treating solid tumors

Novel T cell receptor therapy shows early promise for treating solid tumors

Novel zoonotic Langya virus identified in China

Novel zoonotic Langya virus identified in China

Exploring hematological alterations in COVID-19 patients

Exploring hematological alterations in COVID-19 patients

Urinary SARS-CoV-2 RNA is a prognosticator of COVID-19

Urinary SARS-CoV-2 RNA is a prognosticator of COVID-19

Study links barotrauma to COVID-19 in younger patients

Study links barotrauma to COVID-19 in younger patients

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Factor responsible for formation of white blood cells has regulatory effect on adaptive immunity

Factor responsible for formation of white blood cells has regulatory effect on adaptive immunity

FDA grants accelerated approval to new treatment for refractory multiple myeloma

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Researchers use genetically manipulated virus to combat prostate cancer

Researchers use genetically manipulated virus to combat prostate cancer

FDA extends indication of metastatic breast cancer treatment to include male patients

FDA extends indication of metastatic breast cancer treatment to include male patients

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

Scoring system based on PIRO helps predict mortality in surgical ICU patients with severe sepsis

Scoring system based on PIRO helps predict mortality in surgical ICU patients with severe sepsis

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.